Peptide Skincare & BeautySkin science and ingredient guides

Skin science article

GHK-Cu with Food Safety — Stability & Storage Protocol

GHK-Cu with Food Safety — Stability & Storage Protocol Research from the University of Luxembourg found that copper peptides like GHK-Cu maintain structural integrity at refrigeration temperatures for 90–120 days post-reconstitution, but degrade by more than 4

GHK-Cu with Food Safety — Stability & Storage Protocol

Research from the University of Luxembourg found that copper peptides like GHK-Cu maintain structural integrity at refrigeration temperatures for 90–120 days post-reconstitution, but degrade by more than 40% within 72 hours at 25°C. The difference between effective peptide therapy and wasted investment comes down to one variable most users underestimate: thermal management during storage and handling.

Our team has worked with researchers handling hundreds of peptide protocols across laboratory and clinical settings. The gap between doing GHK-Cu peptide storage right and doing it wrong isn't about sterility. It's about understanding that copper-bound peptides are more temperature-sensitive than most growth factors, and the degradation happens silently.

What is GHK-Cu with food safety?

GHK-Cu with food safety refers to the handling, storage, and preparation protocols required to maintain peptide stability and prevent contamination when working with copper peptide compounds in research or clinical settings. The primary concern isn't dietary interaction. GHK-Cu is administered via injection, not oral consumption. But rather the temperature-dependent degradation that occurs when peptides are stored improperly or exposed to ambient conditions during reconstitution and handling.

The term 'food safety' in this context can be misleading. GHK-Cu isn't taken orally and doesn't interact with food in the digestive sense. What matters is storage protocol. The peptide must be kept at 2–8°C post-reconstitution to prevent copper ion dissociation from the tripeptide backbone, a process that renders the compound biologically inactive. Research published in the Journal of Peptide Science demonstrates that GHK-Cu stored at room temperature for 48 hours shows measurable loss of binding affinity to copper ions, which directly correlates with reduced wound healing activity in fibroblast culture models.

This article covers the specific temperature thresholds that cause irreversible GHK-Cu degradation, the reconstitution steps that introduce contamination risk, and the storage errors that waste expensive peptide inventory before the first injection.

GHK-Cu Stability — Temperature Thresholds and Degradation Kinetics

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a tripeptide-copper chelate where copper ions are bound to the peptide backbone through coordination bonds with nitrogen atoms on histidine and lysine residues. This chelation is thermodynamically stable at low temperatures but becomes reversible as thermal energy increases. At 25°C, the dissociation constant (Kd) rises measurably, allowing copper ions to detach from the peptide.

Lyophilised GHK-Cu powder stored at −20°C maintains potency for 18–24 months according to accelerated stability studies conducted under ICH Q1A guidelines. Once reconstituted with bacteriostatic water, the stability window narrows dramatically: at 2–8°C (standard refrigeration), reconstituted GHK-Cu retains more than 95% potency for 90–120 days. At 25°C (room temperature), degradation accelerates. Potency drops below 80% within 72 hours, and below 60% within one week.

The mechanism is twofold: thermal energy disrupts the coordination bonds holding copper to the peptide, and higher temperatures accelerate oxidative damage to the peptide backbone itself. Copper ions, once dissociated, catalyse further oxidation. Creating a cascade where degradation accelerates over time. Visual inspection cannot detect this. The solution remains clear, colourless, and free of precipitate even when potency has declined by 50%.

Our experience working with research-grade peptides shows that the most common storage failure isn't deliberate mishandling. It's the cumulative effect of brief temperature excursions. A vial left on a laboratory bench for two hours during batch preparation, a refrigerator door left open overnight, or a peptide stored in the door shelf (where temperature fluctuates with each opening) can all reduce usable lifespan from 120 days to fewer than 30.

Reconstitution Protocol — Contamination Risk Points

Reconstitution is the step where lyophilised peptide powder is mixed with sterile bacteriostatic water to create an injectable solution. This process introduces three contamination vectors: airborne particulates, bacterial introduction through the septum, and endotoxin contamination from non-sterile water.

Standard reconstitution protocol for GHK-Cu: work in a clean, low-particulate environment (a laminar flow hood is ideal but not required for most research applications). Wipe the rubber septum on both the peptide vial and the bacteriostatic water vial with 70% isopropyl alcohol and allow to dry for 30 seconds. Draw the required volume of bacteriostatic water using a sterile needle and syringe. For a 50mg vial of GHK-Cu, 5mL of bacteriostatic water yields a 10mg/mL concentration.

Inject the water slowly down the inside wall of the vial, not directly onto the lyophilised cake. Direct impact can denature peptides at the point of contact. Swirl gently to dissolve; do not shake. GHK-Cu typically dissolves within 2–3 minutes at refrigeration temperature. If particulate matter or cloudiness persists after five minutes of gentle swirling, the peptide has likely degraded during storage or shipping. Do not use it.

The biggest mistake researchers make during reconstitution isn't contamination. It's injecting air into the vial while drawing solution. Each time air is introduced, pressure builds inside the vial, and when the needle is withdrawn, that pressure forces a small amount of solution back through the needle tract, potentially carrying contaminants into the vial. The correct technique: equalise pressure by drawing an equivalent volume of air from the vial before injecting solution, or use a vented needle system designed for closed-vial transfer.

Storage After Reconstitution — Practical Cold Chain Management

Once reconstituted, GHK-Cu must be stored at 2–8°C continuously until use. This is the standard pharmaceutical refrigeration range, and it's non-negotiable. A vial stored at 10°C will degrade measurably faster than one stored at 4°C. Every 2-degree increase roughly doubles the degradation rate according to the Arrhenius equation for chemical reaction kinetics.

Store reconstituted vials in the main refrigerator compartment, not the door. Refrigerator doors experience 4–6°C temperature swings every time they're opened, and the cumulative effect over weeks is significant peptide loss. If working in a shared laboratory or clinical refrigerator, label the vial clearly with the reconstitution date and expected expiration (90 days at 2–8°C). Use a pharmaceutical-grade refrigerator with digital temperature logging if available. Consumer refrigerators often cycle between 1°C and 9°C, which accelerates degradation.

For multi-dose vials, minimise the time the vial spends outside refrigeration during dose preparation. Draw the syringe, recap the vial, and return it to the refrigerator immediately. Do not leave it on the counter while preparing the injection site. Each minute at room temperature contributes to cumulative thermal degradation.

Travel presents the biggest cold chain challenge. Lyophilised GHK-Cu powder can tolerate short-term ambient temperature (up to 25°C for 48 hours) without significant loss, but reconstituted peptide cannot. Insulin cooler cases like the FRIO wallet maintain 2–8°C for 36–48 hours using evaporative cooling without ice or electricity. For longer travel, use a portable medical refrigerator with battery backup. These are standard equipment for insulin-dependent diabetics and work identically for peptide storage.

Comparison: GHK-Cu Storage vs Other Research Peptides

GHK-Cu

18–24 months

90–120 days

<72 hours before 20% loss

Copper dissociation + oxidation

More temperature-sensitive than most growth factors due to metal chelation. Requires strict cold chain

BPC-157

24–36 months

60–90 days

5–7 days before 20% loss

Peptide bond hydrolysis

More forgiving than GHK-Cu. Tolerates brief ambient exposure during handling

Thymosin Beta-4

24 months

90 days

3–5 days before 20% loss

Oxidative degradation of cysteine residues

Similar stability profile to GHK-Cu. Both require refrigeration post-reconstitution

Melanotan II

30–60 days

2–3 days before 20% loss

Photodegradation + oxidation

Less stable than GHK-Cu in solution. Must be protected from light as well as heat

Key Takeaways

GHK-Cu maintains more than 95% potency for 90–120 days when stored at 2–8°C post-reconstitution, but degrades by 20–40% within 72 hours at room temperature.

Lyophilised GHK-Cu powder stored at −20°C remains stable for 18–24 months, making pre-reconstitution the safest long-term storage method.

The primary degradation mechanism is copper ion dissociation from the peptide backbone. A thermally driven process that accelerates exponentially above 8°C.

Visual inspection cannot detect potency loss. Solutions remain clear and colourless even when degraded by 50% or more.

Reconstitution errors (direct water impact on lyophilised cake, air injection into vials, contaminated septum) cause more failures than storage temperature in experienced research settings.

Travel requires active cold chain management. Lyophilised peptides tolerate 48 hours at 25°C, but reconstituted solutions do not.

What If: GHK-Cu with Food Safety Scenarios

What If I Left My Reconstituted GHK-Cu Out of the Fridge for 6 Hours?

Discard it if you're working within a strict research protocol where potency variance matters. Six hours at 20–25°C will cause 5–10% potency loss in GHK-Cu. Not catastrophic, but measurable. The real risk is that you don't know the thermal history before it reached you (shipping delays, warehouse storage), so the cumulative degradation may already be higher than you can account for. If the peptide is expensive and replacing it isn't feasible, refrigerate it immediately and use it within 30 days rather than the standard 90-day window.

What If My GHK-Cu Vial Froze in the Refrigerator?

Freezing reconstituted peptide solutions causes ice crystal formation, which can physically shear peptide bonds and disrupt the copper chelation structure. Thaw it slowly at refrigeration temperature (not room temperature or under warm water), inspect for particulate matter or cloudiness, and if it appears clear, use it within two weeks. Freezing doesn't denature all peptides. Some researchers deliberately freeze aliquots for long-term storage. But GHK-Cu's copper coordination makes it more fragile than most. The safest approach: don't freeze it. If your refrigerator routinely freezes items, adjust the thermostat or move the vial away from the coldest zone.

What If I'm Not Sure How Long My Peptide Has Been Reconstituted?

Label every vial with the reconstitution date immediately after mixing. This is non-negotiable in any serious research setting. If you've lost track, assume worst-case: discard after 60 days if stored correctly at 2–8°C, or discard immediately if there's any chance it sat at room temperature for more than 24 hours. Potency testing via HPLC is available through third-party laboratories, but the cost (typically $150–300 per sample) usually exceeds the cost of replacing the vial. The honest answer: if you don't know the reconstitution date, you don't know the potency, and using it introduces uncontrolled variables into your protocol.

The Unvarnished Truth About GHK-Cu Peptide Stability

Here's the honest answer: the term 'GHK-Cu with food safety' is misleading in research contexts because the peptide isn't consumed orally and has zero dietary interaction. The real issue is thermal stability. And the fact that most peptide degradation happens silently, without visual cues, during storage and handling.

Researchers who treat reconstituted GHK-Cu the way they treat growth media or buffer solutions consistently underestimate how quickly potency declines outside refrigeration. The peptide doesn't spoil in the food safety sense (bacterial growth, toxin production). It simply becomes less effective, and there's no way to detect that loss without laboratory analysis. A vial stored at 12°C instead of 4°C for 60 days may look identical to a properly stored vial but deliver 30% less biological activity per injection.

This matters because GHK-Cu is expensive, dose-response relationships are steep (small changes in effective dose produce measurable differences in outcomes), and most research protocols don't include potency verification at the point of use. You're trusting that the peptide you're injecting today has the same activity as the peptide you injected last week. And if your storage protocol is inconsistent, that assumption is wrong.

The single most impactful change researchers can make: use a calibrated thermometer with min/max logging inside the refrigerator where peptides are stored. If the maximum recorded temperature over a 24-hour period exceeds 8°C, your peptides are degrading faster than the manufacturer's stability data predicts. Fix the refrigerator or move the peptides. Everything else is secondary.

GHK-Cu's copper chelation makes it uniquely temperature-sensitive compared to most research peptides. It's not inherently fragile, but it requires cold chain discipline that matches or exceeds what's expected for insulin or monoclonal antibodies. Treat it accordingly, or accept that you're working with a compound of unknown potency.

Reconstitution Timing and Batch Preparation Strategies

One decision that significantly impacts GHK-Cu stability: whether to reconstitute the entire vial at once or reconstitute smaller aliquots as needed. For researchers running multi-week protocols, the trade-off is between convenience (one reconstitution session, multiple doses drawn over time) and maximum stability (fresh reconstitution for each use).

Reconstituting the full vial and storing it refrigerated for 90 days is acceptable if storage conditions are tightly controlled. A pharmaceutical-grade refrigerator with temperature logging, minimal door openings, and stable power supply. Each time a dose is drawn, however, the septum is punctured again, increasing contamination risk and introducing air into the vial headspace. After 10–12 punctures, septum integrity often degrades enough that sterility can no longer be assumed.

An alternative approach: divide the lyophilised powder into smaller aliquots before reconstitution. This requires a sterile environment (ideally a laminar flow hood) and sterile transfer techniques, but it allows researchers to reconstitute only what they'll use within 7–14 days. Lyophilised powder divided into aliquots and stored at −20°C maintains full potency for 18–24 months, so the trade-off is upfront preparation time in exchange for guaranteed potency at each use.

For clinical or research settings where GHK-Cu is administered weekly, reconstituting a two-week supply (enough for two injections) and discarding the vial after the second draw eliminates the uncertainty around long-term refrigerated storage. The peptide cost per dose increases slightly, but potency variance is minimised. Our team has found this approach reduces protocol failures in settings where refrigeration reliability is uncertain.

Peptides degrade. It's thermodynamics, not negligence. The question isn't whether GHK-Cu will lose potency over time, but whether you've structured your handling protocol to keep that loss within acceptable bounds for your application. A 10% potency reduction may be irrelevant for some research contexts and unacceptable for others. Know which situation applies before deciding on storage and reconstitution strategy.

For researchers serious about maintaining peptide integrity across multi-month protocols, explore high-purity research peptides where small-batch synthesis and exact amino-acid sequencing guarantee consistency from vial to vial. When degradation is controlled, protocol outcomes become reproducible.

Frequently Asked Questions

Reconstituted GHK-Cu maintains more than 95% potency for 90–120 days when stored continuously at 2–8°C in a properly functioning refrigerator. This stability window is based on accelerated degradation studies following ICH guidelines and reflects the peptide’s copper chelation stability at low temperatures. Potency declines measurably if the vial is stored above 8°C — even brief temperature excursions (refrigerator door left open, storage in the door shelf) accumulate over weeks and reduce the effective usable lifespan to 30–60 days.

GHK-Cu is administered via subcutaneous injection in research and clinical protocols — it is not taken orally and has no dietary interactions. The term ‘GHK-Cu with food safety’ can be misleading; what matters is proper handling and storage to prevent thermal degradation and contamination during reconstitution. Oral administration of GHK-Cu would result in peptide bond hydrolysis in the stomach (gastric pH of 1.5–3.5 denatures most peptides within minutes) and negligible systemic absorption.

GHK-Cu stored at 25°C (typical room temperature) degrades by 20–40% within 72 hours due to copper ion dissociation from the peptide backbone and oxidative damage. The degradation accelerates over time — by one week at room temperature, potency typically drops below 60%. This loss is not visually detectable; the solution remains clear and colourless even when significantly degraded. Any reconstituted GHK-Cu left at room temperature for more than 24 hours should be discarded.

Lyophilised GHK-Cu powder should be stored at −20°C (standard freezer temperature) in its original sealed vial to maintain potency for 18–24 months. Stability studies show that lyophilised peptides are significantly more stable than reconstituted solutions because water is the primary driver of hydrolysis and oxidation reactions. Once removed from the freezer for reconstitution, allow the vial to reach room temperature before opening to prevent condensation inside the vial, which can introduce moisture and trigger premature degradation.

The most common reconstitution error is injecting bacteriostatic water directly onto the lyophilised peptide cake at high velocity, which can denature peptides at the point of impact through mechanical shear stress. The correct technique is to inject water slowly down the inside wall of the vial and allow it to gently dissolve the powder through diffusion. Swirl the vial gently; do not shake. GHK-Cu typically dissolves within 2–3 minutes at refrigeration temperature — if particulate matter persists after five minutes, the peptide has likely degraded and should not be used.

Freezing reconstituted GHK-Cu is not recommended. Ice crystal formation during freezing can physically shear peptide bonds and disrupt the copper coordination structure, potentially reducing potency by 20–50%. Some researchers freeze peptide aliquots for long-term storage, but GHK-Cu’s metal chelation makes it more fragile than most peptides under freeze-thaw conditions. If a vial accidentally freezes, thaw it slowly at refrigeration temperature, inspect for cloudiness or particulate matter, and use it within two weeks if it appears clear.

Visual inspection cannot reliably detect GHK-Cu degradation — solutions remain clear, colourless, and free of precipitate even when potency has declined by 50% or more. The only definitive method is HPLC (high-performance liquid chromatography) analysis by a third-party laboratory, which costs $150–300 per sample and typically takes 7–10 days. Practical indicators of degradation include storage above 8°C for extended periods, reconstitution date exceeding 120 days, or exposure to room temperature for more than 24 hours. If any of these apply, assume reduced potency and either replace the vial or adjust dosing expectations.

GHK-Cu is a tripeptide-copper chelate where copper ions are coordinated to specific nitrogen atoms on the histidine and lysine residues. This chelation is thermodynamically stable at low temperatures but reversible at higher temperatures. Other copper peptides (like copper gluconate or copper salicylate) bind copper through different mechanisms — ionic bonds, ester linkages — which may have different temperature sensitivity profiles. GHK-Cu’s peptide backbone also introduces hydrolysis risk that non-peptide copper complexes don’t face. The result: GHK-Cu requires stricter cold chain management than most inorganic copper supplements.

Short-term travel (up to 48 hours) is possible with lyophilised GHK-Cu powder, which tolerates ambient temperature for that duration without significant loss. Reconstituted GHK-Cu cannot travel without active cold chain management — use an insulin cooler case like the FRIO wallet, which maintains 2–8°C for 36–48 hours via evaporative cooling without electricity. For longer trips, a portable medical refrigerator with battery backup is required. Each hour at room temperature accelerates degradation; cumulative exposure over a multi-day trip can reduce potency by 30–50%.

Store reconstituted GHK-Cu in the main refrigerator compartment (not the door) where temperature fluctuations are minimal, and label the vial clearly with the reconstitution date and 90-day expiration. Use a calibrated thermometer with min/max logging to verify that the refrigerator maintains 2–8°C continuously — consumer and laboratory refrigerators often cycle between 1°C and 9°C, which accelerates peptide degradation. If the maximum recorded temperature exceeds 8°C, move the peptide to a more stable refrigerator or replace it. Shared refrigerators with frequent door openings require extra vigilance.

The reference edit

Ingredients, questions
& further reading.

Connected source records selected through this article’s public topic index.

01

Formula cabinet

Ingredients & structured notes

Ingredient index

Can GHK-Cu be used with other active ingredients like Vitamin C or Retinol?

  1. 01Yes, GHK-Cu is generally compatible with many other active ingredients. However, we advise applying GHK-Cu first, allowing it to absorb, before applying stronger actives like high-concentration Vitamin C or Retinol. This approach helps minimize pote…
Source · realpeptides.co
02

Product index

Related product references

Product

Lovely Southern GHK-Cu Repair Serum

Lovely Southern GHK-Cu Repair Serum Ingredients in Lovely Southern GHK-Cu Repair Serum explained: benefits, concerns, and detailed analysis of 9 ingredients including Water, Sodium Hyaluron…

Source: skinsort.comView reference →
03

Comparison edit

Read side by side

Comparison Table: GHK-Cu Storage Scenarios

Lyophilized Powder -20°C (Freezer) 1-2+ years Yes (for long-term) Minimizes hydrolysis; keep tightly sealed, dark. 2-8°C (Refrigerator) Several months Yes (for medium-term) Good for shorter…

04

Ask the journal

Related questions

01What If My Post-Treatment Ceruloplasmin Is Higher Than Baseline?

Elevated ceruloplasmin (>60 mg/dL) post-treatment suggests one of two things: therapeutic copper delivery to tissues (expected response) or acute-phase inflammatory reaction (pathological). Distinguish between them by checking hsCRP simultaneously. If hsCRP dropped and ceruloplasmin rose, the elevation is therapeutic. Copper is being mobilised for tissue repair. If both hsCRP and ceruloplasmin rose, the elevation signals inflammation unrelated to GHK-Cu. Persistent ceruloplasmin >70 mg/dL warrants adding zinc (25–50 mg/day elemental) to balance copper-zinc ratio and rechecking labs in 4 weeks.

Source · realpeptides.co
02What If the Injection Site Is Far from the Target Wound?

Subcutaneous peptides diffuse through interstitial fluid over a limited radius. Research using radiolabeled GHK-Cu found peak concentrations within 2–3cm of the injection site and negligible levels beyond 5cm. Injecting GHK-Cu or TB-500 in the abdomen to treat a distal extremity wound means systemic dilution reduces local bioavailability by an estimated 60–80%. Optimal technique: inject within 1–2cm of the wound margin, avoiding direct intralesional administration that disrupts granulation tissue. For large or multiple wounds, divide the total dose across several proximal injection sites rather than concentrating it in one location.

Source · realpeptides.co
03What If I Use GHK-Cu Topically — Will It Reach Cartilage?

No. Cartilage is avascular (no blood supply) and surrounded by synovial fluid inside the joint capsule. Topical application cannot penetrate that barrier. GHK-Cu studied osteoarthritis used direct intra-articular injection or implanted hydrogels to deliver the peptide into the joint space. Topical GHK-Cu may benefit skin wound healing (well-documented in dermatological research) but has no pathway to reach cartilage tissue in a knee, hip, or shoulder joint.

Source · realpeptides.co
04What If I Accidentally Inject Air Into a Vein?

Subcutaneous injection technique with 27–30 gauge needles inserted at 45–90 degree angles into pinched skin makes venous puncture anatomically unlikely. Veins at the subcutaneous layer are small-bore and collapse under the mechanical pressure of pinching. Even if a needle tip enters a superficial vein, volumes below 3mL delivered slowly don't produce symptoms. The air dissolves into venous blood or is filtered by pulmonary capillaries without forming occlusive bubbles. Clinical case reports of air embolism from subcutaneous injection don't exist in peer-reviewed literature because the mechanism doesn't occur at these volumes and injection sites.

Source · realpeptides.co
05What If My CRP Doesn't Drop After 6 Weeks of GHK-Cu?

Persistent CRP elevation (above 3.0 mg/L) after 6 weeks suggests one of three issues: the dose is insufficient, the peptide has degraded due to improper storage, or the inflammation is driven by a source GHK-Cu doesn't address (e.g., visceral adiposity, chronic infection, autoimmune activity). Verify storage first: GHK-Cu must be stored at 2–8°C after reconstitution and used within 30 days. Temperature excursions above 8°C denature the peptide irreversibly. If storage was correct, consider increasing the dose by 50% or switching to subcutaneous administration if you were using topical application (systemic bioavailability is significantly higher with injection). If CRP remains elevated after dose adjustment and confirmed peptide integrity, the inflammation may require concurrent intervention. Dietary modification, omega-3 supplementation, or medical evaluation for underlying inflammatory conditions that peptides alone won't resolve.

Source · realpeptides.co
05

Source shelf

Research & excerpts

Research note

GHK-Cu Component of the KLOW Stack: Skin, Collagen, and Anti-Aging Research

Research Notice: This article covers research on KLOW Stack research peptide blend — available from Palmetto Peptides for laboratory use only. Research Use Only Disclaimer: All peptides listed on this page are sold exclusively for in vitro and legitimate laboratory research purposes. They are not intended for human consumption, veterinary use, or any clinical application. The information in this article is for scientific and educational reference only and does not constitute medical advice. All research use must comply with applicable federal, state, and institutional regulations. Palmetto Peptides complies fully with all applicable FDA guidelines. Last Updated: July 6, 2026 | Reading Time: Approximately 6 minutes | Author: Palmetto Peptides Research Team

Source · palmettopeptides.com

Research note

Research Protocol Considerations

CNS delivery challenges: GHK-Cu’s access to the CNS following peripheral administration is not well characterised — the blood-brain barrier limits passage of many peptides. Research examining CNS effects of peripherally administered GHK-Cu should include measurement of brain copper levels (ICP-MS or ICP-OES) and GHK-Cu peptide in brain tissue (LC-MS/MS) to confirm whether the peptide or its copper cargo reaches neural targets. Intranasal administration offers a route that partially bypasses the BBB via olfactory/trigeminal pathways and merits investigation for CNS-targeted GHK-Cu research. Copper toxicity monitoring: Copper is an essential trace element with a narrow therapeutic window — excess copper generates ROS through Fenton chemistry and contributes to neurodegeneration in copper overload conditions (Wilson’s disease). Research protocols using GHK-Cu should include copper level monitoring in plasma and brain tissue and histopathological assessment for copper-associated toxicity at the doses used. Gene expression profiling: Given GHK-Cu’s documented capacity to modulate large gene sets, RNA-Seq of brain tissue from GHK-Cu-treated animals provides the most comprehensive mechanistic characterisation — identifying which of the many hypothesised CNS mechanisms are actually engaged at research-relevant doses. Pathway analysis of differentially expressed genes can prioritise mechanisms for follow-up mechanistic experiments.

Source · peptideslabuk.com